Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Ruxolitinib cream may help treat severe hair loss in children.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Upadacitinib may effectively treat alopecia areata without side effects.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Certain alkaloids could help create new coronavirus drugs.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Vitamin A treatment reduced abnormal cell growth and improved skin conditions in rats with tumors.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Baricitinib helps regrow hair in teens with severe alopecia areata.